Houlihan Lokey Advises Teijin Pharma
Teijin Pharma Limited in-licensing Japan rights for three hormone drugs from Ascendis Pharma
Buyside Advisor
Request more information regarding this transaction.
RELATED: Healthcare, Global Pharmaceuticals
Teijin Pharma Limited in-licensing Japan rights for three hormone drugs from Ascendis Pharma
Buyside Advisor
Request more information regarding this transaction.
RELATED: Healthcare, Global Pharmaceuticals